Terug
41
Ook genoteerd als
ANSLY
OTC
Dagbereik
€ 22,74
€ 22,74
52-Weeksbereik
€ 18,00
€ 25,00
Volume
2.000
50D / 200D Gem.
€ 22,83
/
€ 20,36
Vorige Slotkoers
€ 22,74
Quick Summary
Koershistorie
Financiële Trends
Sectorvergelijking
vs Healthcare sector mediaan (631 peers)
| Metriek | Aandeel | Sector Mediaan |
|---|---|---|
| P/E | 32,3 | 0,2 |
| P/B | 1,7 | 3,0 |
| ROE % | 5,3 | 3,6 |
| Net Margin % | 5,1 | 3,8 |
| Rev Growth 5Y % | -0,5 | 9,9 |
| D/E | 0,4 | 0,2 |
Koersdoel Analisten
Geen analistendekking beschikbaar
Winstschattingen
| Periode | WPA Sch. | Omzet Sch. | Analisten |
|---|---|---|---|
| FY2029 |
€ 1,80
€ 1,75 – € 1,87
|
2,30B | 5 |
| FY2028 |
€ 1,66
€ 1,61 – € 1,72
|
2,23B | 6 |
| FY2027 |
€ 1,56
€ 1,52 – € 1,62
|
2,15B | 5 |
No quarterly estimates available
Earnings Surprises
Last 8 quarters
| Quarter | Est. EPS | Actual EPS | Surprise |
|---|---|---|---|
| 2026-02-15 | € 0,65 | € 0,62 | -3,4% |
| 2025-08-24 | € 0,68 | € 0,22 | -68,1% |
| 2025-02-11 | € 0,55 | € 0,22 | -60,5% |
| 2024-08-20 | € 0,53 | € 0,29 | -46,0% |
| 2024-04-08 | € 0,41 | € 0,11 | -73,1% |
| 2023-06-30 | € 0,64 | € 0,43 | -32,4% |
| 2022-12-30 | € 0,55 | € 0,35 | -36,9% |
| 2022-06-30 | € 0,67 | € 0,42 | -36,8% |
Dividend History
7 yr streakYield
0,02%
Payout Ratio
0,63%
Growth (3Y)
-3,26%
Growth (5Y)
0,08%
| Ex-Date | Payment Date | Amount | Yield |
|---|---|---|---|
| Feb 24, 2026 | Mar 13, 2026 | € 0,27 | 2,40% |
| Aug 29, 2025 | Sep 18, 2025 | € 0,28 | 2,45% |
| Feb 14, 2025 | Mar 06, 2025 | € 0,22 | 1,89% |
| Aug 27, 2024 | Sep 12, 2024 | € 0,22 | 2,42% |
| Feb 26, 2024 | Mar 14, 2024 | € 0,17 | 2,59% |
| Aug 18, 2023 | Sep 07, 2023 | € 0,26 | 2,60% |
| Feb 20, 2023 | Mar 09, 2023 | € 0,20 | 2,55% |
| Aug 29, 2022 | Sep 15, 2022 | € 0,31 | 3,47% |
| Feb 21, 2022 | Mar 09, 2022 | € 0,24 | 4,26% |
| Aug 30, 2021 | Sep 16, 2021 | € 0,44 | 2,64% |
| Feb 22, 2021 | Mar 10, 2021 | € 0,33 | 1,98% |
| Aug 31, 2020 | Sep 17, 2020 | € 0,28 | 1,70% |
| Feb 24, 2020 | Mar 12, 2020 | € 0,22 | 2,27% |
| Aug 16, 2019 | Sep 05, 2019 | € 0,26 | 2,58% |
| Feb 22, 2019 | Mar 14, 2019 | € 0,21 | 3,08% |
| Aug 24, 2018 | Sep 13, 2018 | € 0,25 | 2,98% |
| Feb 16, 2018 | Mar 08, 2018 | € 0,21 | 2,66% |
| Aug 18, 2017 | Sep 08, 2017 | € 0,24 | 2,50% |
| Feb 17, 2017 | Mar 10, 2017 | € 0,20 | 2,69% |
| Aug 19, 2016 | Sep 08, 2016 | € 0,24 | 2,51% |
Belangrijkste Punten
Revenue declined -0,45% annually over 5 years
Earnings grew 32,81% over the past year
Debt/Equity of 0,41 — conservative balance sheet
Generating 170,00M in free cash flow
P/E of 32,30 — premium valuation
Revenue growth is accelerating — 1Y growth exceeds 5Y average by 24,16%
Groei
Revenue Growth (5Y)
-0,45%
Revenue (1Y)23,71%
Earnings (1Y)32,81%
FCF Growth (3Y)33,51%
Kwaliteit
Return on Equity
5,27%
ROIC2,95%
Net Margin5,07%
Op. Margin5,45%
Veiligheid
Debt / Equity
0,41
Current Ratio2,13
Interest Coverage2,32
Waardering
P/E Ratio
32,30
Forward P/E15,89
P/B Ratio1,67
EV/EBITDA35,28
Dividend Yield0,02%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 23,71% | Revenue Growth (3Y) | 10,72% |
| Earnings Growth (1Y) | 32,81% | Earnings Growth (3Y) | -17,23% |
| Revenue Growth (5Y) | -0,45% | Earnings Growth (5Y) | -19,89% |
| Profitability | |||
| Revenue (TTM) | 2,00B | Net Income (TTM) | 101,60M |
| ROE | 5,27% | ROA | 3,06% |
| Gross Margin | 41,18% | Operating Margin | 5,45% |
| Net Margin | 5,07% | Free Cash Flow (TTM) | 170,00M |
| ROIC | 2,95% | FCF Growth (3Y) | 33,51% |
| Safety | |||
| Debt / Equity | 0,41 | Current Ratio | 2,13 |
| Interest Coverage | 2,32 | ||
| Dividends | |||
| Dividend Yield | 0,02% | Payout Ratio | 0,63% |
| Dividend Growth (3Y) | -3,26% | Dividend Growth (5Y) | 0,08% |
| Consecutive Div Years | 7 yrs | ||
| Valuation | |||
| P/E Ratio | 32,30 | Forward P/E | 15,89 |
| P/B Ratio | 1,67 | P/S Ratio | 1,64 |
| PEG Ratio | 1,27 | Forward PEG | N/A |
| EV/EBITDA | 35,28 | Fwd EV/EBITDA | 12,01 |
| Forward P/S | 1,59 | Fwd Earnings Yield | 6,29% |
| FCF Yield | 5,18% | ||
| Market Cap | 3,28B | Enterprise Value | 3,85B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 2,00B | 1,62B | 1,63B | 1,85B | 2,04B |
| Net Income | 101,60M | 76,50M | 148,30M | 158,70M | 246,70M |
| EPS (Diluted) | 0,71 | 0,59 | 1,15 | 1,18 | 1,91 |
| Gross Profit | 825,00M | 624,80M | 604,22M | 625,19M | 807,21M |
| Operating Income | 109,10M | 129,30M | 210,50M | 236,60M | 343,82M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 3,32B | 3,24B | 2,52B | 2,51B | 2,74B |
| Total Liabilities | 1,34B | 1,33B | 913,07M | 949,48M | 1,17B |
| Shareholders' Equity | 1,96B | 1,89B | 1,60B | 1,54B | 1,55B |
| Total Debt | 805,60M | 857,20M | 493,15M | 485,74M | 515,53M |
| Cash & Equivalents | 238,30M | 912,30M | 159,03M | 206,18M | 240,21M |
| Current Assets | 1,11B | 1,62B | 909,88M | 984,38M | 1,17B |
| Current Liabilities | 522,00M | 423,40M | 413,63M | 360,26M | 549,93M |
Strategiescores
This stock passed the criteria for 1 strategy
Score = fit strength (0–100)
Rank = position among all matches
Custom
Cash Flow Compounder
#606 of 1049
Recente Activiteit
Ingestapt
Cash Flow Compounder
Mar 24, 2026